Dong-Kug Choi Selected Research

Epilepsy (Aura)

1/2022	Molecular Mechanisms and Therapeutic Potential of α- and β-Asarone in the Treatment of Neurological Disorders.
1/2019	Taurine and its analogs in neurological disorders: Focus on therapeutic potential and molecular mechanisms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dong-Kug Choi Research Topics

Disease

35	Parkinson Disease (Parkinson's Disease) 10/2022 - 03/2002
34	Neuroinflammatory Diseases 03/2024 - 08/2006
17	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2023 - 03/2002
12	Inflammation (Inflammations) 01/2019 - 04/2003
9	Cognitive Dysfunction 03/2024 - 01/2012
7	Mitochondrial Diseases (Mitochondrial Disease) 03/2024 - 01/2012
7	Neuroblastoma 04/2022 - 06/2003
5	Nervous System Diseases (Neurological Disorders) 06/2023 - 01/2018
5	Neoplasms (Cancer) 10/2020 - 09/2002
3	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 09/2016
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021 - 04/2005
3	Chronic Disease (Chronic Diseases) 01/2018 - 01/2017
3	Hypoxia (Hypoxemia) 01/2016 - 01/2015
3	Gliosis 08/2013 - 04/2005
2	Obesity 06/2023 - 01/2018
2	Memory Disorders (Memory Loss) 09/2022 - 01/2021
2	B-Cell Lymphoma (Lymphoma, B Cell) 04/2022 - 10/2020
2	Epilepsy (Aura) 01/2022 - 01/2019
2	Amnesia (Dissociative Amnesia) 05/2021 - 08/2017
2	Huntington Disease (Huntington's Disease) 01/2021 - 01/2005
2	Brain Diseases (Brain Disorder) 01/2018 - 12/2016
2	Pain (Aches) 04/2015 - 01/2013
2	Hypokinesia (Bradykinesia) 04/2015 - 01/2013
2	Adenocarcinoma 10/2002 - 09/2002
1	Dysbiosis 03/2024
1	Hyperpigmentation 12/2023
1	Pathologic Processes 01/2021
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2019
1	Wounds and Injuries (Trauma) 01/2019
1	Stroke (Strokes) 01/2019
1	Infections 01/2018

Drug/Important Bio-Agent (IBA)

15	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 04/2021 - 03/2002
14	Proteins (Proteins, Gene)FDA Link 11/2023 - 05/2007
9	CytokinesIBA 01/2021 - 01/2012
7	Scopolamine (Hyoscine)FDA Link 09/2023 - 08/2017
7	Neuroprotective AgentsIBA 06/2023 - 01/2005
7	AntioxidantsIBA 06/2023 - 01/2012
7	NeurotoxinsIBA 09/2016 - 04/2003
6	1-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA 04/2022 - 01/2011
5	asaroneIBA 01/2022 - 01/2012
5	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 01/2012
4	SynucleinsIBA 10/2022 - 01/2012
4	LipopolysaccharidesIBA 05/2021 - 04/2011
4	Cholinergic Agents (Cholinergics)IBA 07/2019 - 01/2012
4	NF-kappa B (NF-kB)IBA 01/2017 - 05/2010
3	Caspase 3 (Caspase-3)IBA 04/2022 - 12/2009
3	Oxygen (Dioxygen)IBA 01/2016 - 01/2015
3	Transcription Factors (Transcription Factor)IBA 06/2015 - 12/2012
3	Free RadicalsIBA 09/2012 - 01/2003
3	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2012 - 01/2011
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2009 - 04/2003
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 09/2023 - 01/2018
2	dioscinIBA 09/2022 - 04/2022
2	Nerve Growth Factors (Neurotrophins)IBA 01/2022 - 01/2021
2	CaspasesIBA 04/2021 - 01/2021
2	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2021 - 01/2018
2	RotenoneIBA 01/2021 - 08/2011
2	PhytochemicalsIBA 01/2021 - 01/2018
2	gintoninIBA 01/2021 - 09/2018
2	LipidsIBA 01/2020 - 10/2018
2	Lipid NanoparticlesIBA 03/2019 - 01/2018
2	Taurine FDA Link 01/2019 - 01/2015
2	IronIBA 01/2016 - 01/2012
2	CannabinoidsIBA 04/2015 - 01/2013
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2014 - 01/2003
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 03/2012 - 12/2009
2	EnzymesIBA 01/2012 - 07/2005
2	DNA (Deoxyribonucleic Acid)IBA 10/2009 - 08/2007
2	OsteonectinIBA 10/2002 - 09/2002
1	Carotenoids (Carotene)IBA 03/2024
1	FlavonoidsIBA 03/2024
1	AcidsIBA 03/2024
1	CosmeticsIBA 12/2023
1	CalciumIBA 11/2023
1	3-azido-2,7-naphthalene disulfonateIBA 06/2023
1	Antihypertensive Agents (Antihypertensives)IBA 06/2023
1	Hypoglycemic Agents (Hypoglycemics)IBA 06/2023
1	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 01/2021
1	AnhydridesIBA 11/2020
1	4-trifluoromethylsalicylic acid (HTB)IBA 11/2020
1	Messenger RNA (mRNA)IBA 10/2020
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 10/2020
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 10/2020
1	Complement System Proteins (Complement)IBA 10/2020
1	InflammasomesIBA 01/2020
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020
1	QuercetinIBA 10/2019
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 10/2019
1	GTP-Binding Proteins (G-Protein)IBA 10/2019
1	CurcuminIBA 03/2019
1	PolyphenolsIBA 01/2019
1	irilin BIBA 01/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019
1	ChemokinesIBA 10/2018
1	GinsenosidesIBA 09/2018
1	Liposomes (Liposome)IBA 09/2018
1	ginsenoside M1IBA 09/2018

Therapy/Procedure

8	Therapeutics 04/2022 - 04/2015
2	Oral Administration 11/2020 - 07/2019
2	East Asian Traditional Medicine (Oriental Medicine) 04/2015 - 11/2013